Search Results - "Rodrigues, Debora G"
-
1
Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study
Published in Cancer chemotherapy and pharmacology (2009)“…Purpose In animal experiments paclitaxel oleate associated with a cholesterol-rich nanoemulsion concentrated in the neoplastic tissues and showed reduced…”
Get full text
Journal Article -
2
Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone
Published in Growth hormone & IGF research (01-10-2016)“…Abstract Objective To extend available dosing options in the treatment of growth hormone deficiency, a comparative pharmacokinetic and pharmacodynamic phase-1…”
Get full text
Journal Article -
3
Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit
Published in Atherosclerosis (01-04-2008)“…Abstract A cholesterol-rich nanoemulsion (LDE) that resembles LDL binds to the LDL receptors and after injection into the blood stream may concentrate in cells…”
Get full text
Journal Article -
4
Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers
Published in Cancer chemotherapy and pharmacology (01-01-2007)“…A cholesterol-rich nanoemulsion termed LDE concentrates in cancer tissues after injection into the bloodstream. The association of a derivatized paclitaxel to…”
Get full text
Journal Article -
5
Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion : in vitro and in vivo studies
Published in Cancer chemotherapy and pharmacology (01-06-2005)“…A cholesterol-rich microemulsion or nanoparticle termed LDE concentrates in cancer tissues after injection into the bloodstream. Here the cytotoxicity,…”
Get full text
Journal Article -
6
Brazil: An emerging partner in drug R&D
Published in IDrugs : the investigational drugs journal (01-08-2009)“…With the need for innovation in drug discovery and development and changes to patent laws that are enabling greater IP protection, many pharmaceutical…”
Get more information
Journal Article -
7
Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion
Published in Journal of pharmacy and pharmacology (01-06-2006)“…A cholesterol‐rich nanoemulsion (LDE) may be used as a vehicle to target antineoplastic drugs against cancer cells. The association of an etoposide derivative…”
Get full text
Journal Article -
8
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease
Published in Cancer chemotherapy and pharmacology (2004)“…Previously we have shown that cholesterol-rich microemulsions that bind to LDL receptors have the ability to concentrate in acute myeloid leukemia cells and in…”
Get full text
Journal Article -
9
Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide
Published in Journal of pharmacy and pharmacology (01-12-2003)“…ABSTRACT A cholesterol‐rich microemulsion (LDE) that binds to low‐density lipoprotein (LDL) receptors is selectively taken up by malignant cells that…”
Get full text
Journal Article -
10
Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients
Published in Cancer chemotherapy and pharmacology (01-06-2002)“…We had previously shown in acute leukemia and in breast and ovary carcinoma patients that a cholesterol-rich emulsion (LDE) that binds to receptors for…”
Get full text
Journal Article -
11
Mpox outbreak in Rio de Janeiro, Brazil: A translational approach
Published in Journal of medical virology (01-05-2024)“…Mpox is a zoonotic disease historically reported in Africa. Since 2003, limited outbreaks have occurred outside Africa. In 2022, the global spread of cases…”
Get full text
Journal Article -
12
Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel
Published in Journal of pharmacy and pharmacology (01-06-2002)“…A cholesterol‐rich emulsion (LDE) is taken up by malignant cells which over‐express low‐density lipoprotein (LDL) receptors and thus may be used as a carrier…”
Get full text
Journal Article -
13
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease
Published in Cancer chemotherapy and pharmacology (01-01-2004)“…Purpose: Previously we have shown that cholesterol-rich microemulsions that bind to LDL receptors have the ability to concentrate in acute myeloid leukemia…”
Get full text
Journal Article -
14
Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion
Published in Journal of pharmacy and pharmacology (01-06-2006)“…A cholesterol-rich nano-emulsion (LDE) may be used as a vehicle to target antineoplastic drugs against cancer cells. The association of an etoposide derivative…”
Get full text
Journal Article